Rate My Professor Naresh Kumar

Professor Kumar's research centers on synthetic organic chemistry, natural products chemistry, medicinal chemistry, heterocyclic chemistry, and biomaterials, with a focus on designing and synthesizing biologically active molecules for medical and industrial applications. Key projects include quorum sensing inhibitors and antimicrobial peptide mimics targeting antibiotic-resistant bacteria like Pseudomonas aeruginosa, inhibitors of bacterial transcription initiation, novel anticancer agents such as heterocyclic analogues of isoflavones and USP5 inhibitors, antimicrobial biomaterials for bone grafts, orthopaedic implants, and hydrogels, as well as PFAS remediation and disinfection strategies against microbes, viruses, and microbiologically induced corrosion. His group employs molecular modelling, analytical chemistry, and biological screening in collaborations with experts in biology and engineering. Over his career, he has produced 573 journal articles, 10 book chapters, 46 conference papers, and 5 patents, supported by grants from the Australian Research Council and National Health and Medical Research Council. Highly cited works include 'Attenuation of Pseudomonas aeruginosa virulence by quorum sensing inhibitors' (2003), 'Quorum-sensing cross talk: isolation and chemical characterization of cyclic dipeptides from Pseudomonas aeruginosa and other Gram-negative bacteria' (1999), and 'A new era of antibiotics: the clinical potential of antimicrobial peptides' (2020). His publications have accumulated over 20,000 citations, underscoring his substantial influence in organic and medicinal chemistry.